Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis

ClinicalTrials.gov ID: NCT00805025

Public ClinicalTrials.gov record NCT00805025. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 19, 2026, 4:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multicenter Trial to Validate the Quality of Life Questionnaire-Bronchiectasis and to Evaluate Perception of Symptom Improvement Following One Course of Aztreonam for Inhalation Solution (AZLI) in Subjects With Bronchiectasis and Gram-negative Bacteria in the Airways

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Over the 70-day study period, eligible patients visited the study clinic every 2 weeks (total of 6 visits) and received a 28-day course of aztreonam for inhalation solution (AZLI). The Quality of Life-Bronchiectasis (QOL-B) questionnaire was completed at several time points during the study, in additional to pulmonary function testing and other standard procedures.

Study identification

NCT ID: NCT00805025
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Gilead Sciences; Industry
Enrollment: 89 participants

Conditions and interventions

Conditions

Bronchiectasis

Interventions

AZLI Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 2008 (Type not available)
Primary completion: Oct 2009 (Actual)
Completion: Oct 2009 (Actual)
Last update posted: Mar 20, 2014

2008 – 2009

United States locations

U.S. sites: 24
U.S. states: 20
U.S. cities: 24

Facility	City	State	ZIP	Site status
Not listed	Birmingham	Alabama	35209	—
Not listed	Peoria	Arizona	85381	—
Not listed	Phoenix	Arizona	85006	—
Not listed	Orange	California	92868	—
Not listed	Denver	Colorado	80206	—
Not listed	Farmington	Connecticut	06030	—
Not listed	New Haven	Connecticut	06519	—
Not listed	Washington D.C.	District of Columbia	20007	—
Not listed	Miami	Florida	33136	—
Not listed	Atlanta	Georgia	30342	—
Not listed	Marietta	Georgia	30060	—
Not listed	Chicago	Illinois	60637	—
Not listed	Olathe	Kansas	66061	—
Not listed	Boston	Massachusetts	02118	—
Not listed	Chesterfield	Missouri	63017	—
Not listed	Mineola	New York	11501	—
Not listed	New York	New York	10032	—
Not listed	Chapel Hill	North Carolina	27599	—
Not listed	Portland	Oregon	97239	—
Not listed	Philadelphia	Pennsylvania	19104	—
Not listed	Charleston	South Carolina	29425	—
Not listed	Tyler	Texas	75708	—
Not listed	Charlottesville	Virginia	22908	—
Not listed	Madison	Wisconsin	53792	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00805025, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 20, 2014 · Synced Oct 19, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00805025 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →